Results 231 to 240 of about 104,235 (402)

Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14) [PDF]

open access: yes, 2018
Levonis, Stephan M   +3 more
core   +1 more source

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida   +17 more
wiley   +1 more source

Rituximab-Induced Esophageal Ulcers and Strictures Presenting as Dysphagia. [PDF]

open access: yesACG Case Rep J
Abdulrazzak MA   +4 more
europepmc   +1 more source

ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)

open access: yesAmerican Journal of Gastroenterology, 2013
E. Dellon   +5 more
semanticscholar   +1 more source

Concurrent Diagnosis of Superficial Esophageal Cancer and Esophageal Achalasia: A Case Report and Literature Review

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT We report a case of a 70‐year‐old woman with esophageal achalasia and concurrent superficial esophageal squamous cell carcinoma. Three adjacent superficial lesions were resected en bloc by endoscopic submucosal dissection (ESD), with no lymphovascular invasion.
Ai Katsumi   +9 more
wiley   +1 more source

Evolving diagnostic and therapeutic methods in corrosive esophagitis: Evaluation of a diagnostic and therapeutic algorithm based on 26 years of experience. [PDF]

open access: yesTurk Gogus Kalp Damar Cerrahisi Derg
Pirzirenli MG   +7 more
europepmc   +1 more source

Clinical Characteristics and Outcomes of Incomplete Cardia Reconstruction Cases Following Multiple Anti‐reflux Mucosectomy/Anti‐reflux Mucosal Ablation Treatments

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Introduction Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) are novel endoscopic treatments for proton pump inhibitor or potassium‐competitive acid blocker‐refractory gastroesophageal reflux disease. These procedures induce scarring of the artificial ulcer at the gastric cardia, which tightens the enlarged cardiac ...
Ippei Tanaka   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy